当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 资产负债表

尔康制药

(300267)

  

流通市值:34.28亿  总市值:49.71亿
流通股本:14.22亿   总股本:20.63亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金744,349,595.87501,644,600.73544,929,019.53539,803,972.59
应收票据及应收账款146,992,409.94119,305,797.65144,028,020.42166,139,425.22
其中:应收票据37,838,273.192,123,784.8413,153,846.3231,420,161.08
应收账款109,154,136.75117,182,012.81130,874,174.1134,719,264.14
应收款项融资30,806,644.0631,659,024.1134,496,950.9414,019,469.3
预付款项8,090,607.37151,051,645.0954,018,159.57111,049,444.02
其他应收款合计18,172,661.159,194,301.2410,858,647.748,168,777.62
存货691,603,264.38731,119,490.7829,667,552.54853,416,396.16
其他流动资产90,879,770.27150,982,900.98130,773,310.72169,577,287.75
流动资产平衡项目0000
流动资产合计1,731,013,553.041,694,957,760.51,758,508,679.431,863,153,004.68
非流动资产:
长期股权投资120,229,041.21124,736,149.08125,321,624.33125,594,266.48
其他权益工具投资50,000,00050,000,00050,000,00050,000,000
投资性房地产81,288,053.0182,089,422.8282,890,792.6684,415,328.19
固定资产2,577,832,463.042,618,286,470.722,625,146,735.982,626,353,229.44
在建工程220,890,498.68214,146,482.42171,687,828.4868,554,391.6
使用权资产118,606,849.27120,709,206.06122,734,246.8119,134,016.86
无形资产378,033,817.06384,880,206.28391,204,164.69400,926,526.85
商誉2,003,166.5610,008,171.5410,008,171.5410,008,171.54
长期待摊费用12,076,529.0916,717,517.0317,813,615.718,419,400.55
递延所得税资产152,137,202.17161,868,592.29165,013,515.53169,328,656.61
其他非流动资产34,957,684.6145,996,589.1364,427,742.0264,450,772.01
非流动资产平衡项目0000
非流动资产合计3,748,055,304.73,829,438,807.373,826,248,437.733,737,184,760.13
资产平衡项目0000
资产总计5,479,068,857.745,524,396,567.875,584,757,117.165,600,337,764.81
流动负债:
短期借款341,889,166.67149,000,000149,000,000199,000,000
交易性金融负债538,400---
应付票据及应付账款122,299,149.22139,031,294.34165,324,874.27169,703,383.03
应付账款122,299,149.22139,031,294.34165,324,874.27169,703,383.03
合同负债47,013,865.0936,927,705.7832,911,358.6334,510,835.85
应付职工薪酬23,857,997.4110,342,152.1110,529,211.0511,580,175.21
应交税费9,303,386.6914,450,624.6618,970,106.2413,295,360.52
其他应付款合计31,848,209.8931,902,980.8732,921,270.6337,786,855.34
一年内到期的非流动负债2,156,803.172,082,826.32,245,987.583,453,920.32
其他流动负债24,394,033.644,639,049.094,181,065.584,474,212.17
流动负债平衡项目0000
流动负债合计603,301,011.78388,376,633.15416,083,873.98473,804,742.44
非流动负债:
租赁负债1,167,270.831,146,461.311,628,650.232,105,277.29
递延收益18,385,950.1918,570,895.5819,968,091.0121,558,286.34
递延所得税负债46,200,440.2649,499,411.6552,622,690.4854,164,535.65
非流动负债平衡项目0000
非流动负债合计65,753,661.2869,216,768.5474,219,431.7277,828,099.28
负债平衡项目0000
负债合计669,054,673.06457,593,401.69490,303,305.7551,632,841.72
所有者权益(或股东权益):
实收资本(或股本)2,062,604,8702,062,604,8702,062,604,8702,062,604,870
资本公积1,019,459,930.441,005,421,601.151,005,421,601.151,005,421,601.15
其他综合收益76,091,641.59100,922,677.44111,193,268.9224,846,972.04
专项储备426,836.46674,996.69807,008.37886,828.72
盈余公积129,884,442.27129,884,442.27129,884,442.27129,884,442.27
未分配利润1,547,578,057.411,782,764,457.841,794,641,121.481,830,647,457.13
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,836,045,778.175,082,273,045.395,104,552,312.195,054,292,171.31
少数股东权益-26,031,593.49-15,469,879.21-10,098,500.73-5,587,248.22
股东权益平衡项目0000
股东权益合计4,810,014,184.685,066,803,166.185,094,453,811.465,048,704,923.09
负债和股东权益合计5,479,068,857.745,524,396,567.875,584,757,117.165,600,337,764.81
公告日期2024-04-252023-10-232023-08-282023-04-27
审计意见(境内)标准无保留意见
TOP↑